Literature DB >> 16294020

Combining EGFR targeted therapy with chemotherapy in pancreatic cancer: is timing important?

Gregory J Riely1, William Pao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16294020     DOI： 10.4161/cbt.4.10.2102

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  3 in total

1.  The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer.

Authors:  Najwa El Kadi; Luo Wang; April Davis; Hasan Korkaya; Alexander Cooke; Varun Vadnala; Noah A Brown; Bryan L Betz; Marilia Cascalho; Gregory P Kalemkerian; Khaled A Hassan
Journal:  Cancer Res       Date:  2018-10-17       Impact factor: 12.701

2.  A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.

Authors:  El Mustapha Bahassi; Ya-Qin Li; Trisha M Wise-Draper; Li Deng; Jiang Wang; Colleen N Darnell; Keith M Wilson; Susanne I Wells; Peter J Stambrook; Olivier Rixe
Journal:  Eur J Cancer       Date:  2013-04-08       Impact factor: 9.162

3.  High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.

Authors:  Dan Su; Dadong Zhang; Kaiyan Chen; Jing Lu; Junzhou Wu; Xinkai Cao; Lisha Ying; Qihuang Jin; Yizhou Ye; Zhenghua Xie; Lei Xiong; Weimin Mao; Fugen Li
Journal:  J Exp Clin Cancer Res       Date:  2017-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.